Health : Medical Research (Grantmaking/Grants Payable)

Cancer Research Institute

The Leader in Immunotherapy

impact data icon

Impact Information is available from our partner, GuideStar

four stars

94.12

29 Broadway, Floor 4 New York, NY 10006
tel: (800) 992-2623   Web Site
EIN: 13-1837442

Board Leadership
Paul C. Shiverick and Andrew K. Tsai
Chairmen

CEO
Jill O'Donnell-Tormey
Chief Executive Officer & Director of Scientific Affairs

  Score
(out of 100)
Rating
Overall Score & Rating 94.12 four stars
  Financial 91.69 four stars
  Accountability & Transparency 100.00 four stars
This rating was published 07/01/2019 and includes data from FY2018, the most recent 990 received at that time.

Save more lives by fueling the discovery and development
of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $357 million to fund more than 3,100 scientists all over the world. With 65 years of experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy.

Save more lives by fueling the discovery and development
of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $357 million to fund more than 3,100 scientists all over the world. With 65 years of experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy.

Impact Information

GuideStar is Charity Navigator's trusted partner in sharing information on how this organization seeks impact.  GuideStar has recognized this organization with a Platinum Seal of Transparency for voluntarily and publicly sharing information about how they measure their progress and results.  Learn More about Impact Information.
Reported Results
Total in 2017
Total number of grants awarded
55
Total dollar amount of grants awarded
17,487,500
This impact information is current as of July 2019, when it was provided to us by GuideStar. At this time, Impact information published on this organization's page has no effect on its rating per our methodology.

Financial

four stars

91.69

Accountability & Transparency

four stars

100.00

This rating was published 07/01/2019 and includes data from FY2018, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
85.3%
  Administrative Expenses 5.4%
  Fundraising Expenses 9.2%
  Fundraising Efficiency $0.09
  Working Capital Ratio (years) 1.70
  Program Expenses Growth 3.7%
  Liabilities to Assets 53.3%
All data for Financial Performance Metrics calculations was provided by Cancer Research Institute on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by Cancer Research Institute on recent 990s filed with the IRS.
REVENUE  
Contributions  
   Contributions, Gifts & Grants $21,221,704
   Federated Campaigns $580,675
   Membership Dues $0
   Fundraising Events $1,855,176
   Related Organizations $0
   Government Grants $0
Total Contributions $23,657,555
   Program Service Revenue $0
Total Primary Revenue $23,657,555
   Other Revenue $1,551,916
TOTAL REVENUE $25,209,471
   
EXPENSES  
   Program Expenses $25,982,390
   Administrative Expenses $1,602,242
   Fundraising Expenses $2,231,545
TOTAL FUNCTIONAL EXPENSES $29,816,177
   
Payments to Affiliates $0
Excess (or Deficit) for the year $-4,606,706
   
Net Assets $52,192,406

Charts

Compensation % of Expenses Paid to Title
$416,188 1.39% Jill O'Donnell-Tormey Chief Executive Officer

Mission

Save more lives by fueling the discovery and development
of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $357 million to fund more than 3,100 scientists all over the world. With 65 years of experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy.

Highly Rated

Charity Name & State Overall Score Overall Rating
Cancer Research Institute (NY) 94.12 four stars
The Multiple Myeloma Research Foundation (CT) 98.23 four stars
Swim Across America (NC) 92.04 four stars
Minnesota Ovarian Cancer Alliance (MN) 91.58 four stars
The Lustgarten Foundation for Pancreatic Cancer Research (NY) 100.00 four stars

Compare These Charities (Highly Rated)

Charity Contact Info

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006
tel: (800) 992-2623
fax: (212) 832-9376
EIN: 13-1837442

Visit Web Site

Board Leadership

Paul C. Shiverick and Andrew K. Tsai
Chairmen

CEO

Jill O'Donnell-Tormey
Chief Executive Officer & Director of Scientific Affairs